| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
13.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,551 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$1,006,995 |
$2,012,670 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
2 |
3 |
| Total Shares Sold |
0 |
11,681 |
63,744 |
167,262 |
| Total Sell Value |
$0 |
$1,906,248 |
$12,326,709 |
$40,328,387 |
| Total People Sold |
0 |
2 |
4 |
7 |
| Total Sell Transactions |
0 |
2 |
8 |
20 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zakrzewski Joseph S |
Director |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
20,000 |
|
- |
|
| Sobieski Steven |
Director |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
20,000 |
|
- |
|
| Sommer Regina O |
Director |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
20,500 |
|
- |
|
| Levangie Daniel J |
Director |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
12,000 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
14,000 |
|
- |
|
| Desisto Duane |
President and CEO |
• • – |
2014-06-02 |
4 |
AS |
$34.75 |
$695,086 |
D/D |
(20,000) |
257,184 |
|
- |
|
| Desisto Duane |
President and CEO |
• • – |
2014-06-02 |
4 |
OE |
$15.09 |
$301,800 |
D/D |
20,000 |
277,184 |
|
- |
|
| Diehl R Anthony |
Secretary and General Counsel |
• • – |
2014-05-08 |
4 |
OE |
$15.09 |
$188,625 |
D/D |
12,500 |
65,746 |
|
- |
|
683 Records found
|
|
Page 28 of 28 |
|
|
3.15 (1.85%) 
